Literature DB >> 15641745

Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis.

R Lor Randall1, Karen H Albritton, Brandon J Ferney, Lester Layfield.   

Abstract

Malignant fibrous histiocytoma (MFH) has been regarded as the most common soft-tissue sarcoma of adult life. Since it was first recognized in the early 1960s, however, MFH has been plagued by controversy in terms of both its histogenesis and its validity as a clinicopathologic entity. The latest World Health Organization classification no longer includes MFH as a distinct diagnostic category but rather as subtypes of an undifferentiated pleomorphic sarcoma. In this article, we review the current understanding of the histologic subtype classification of tumors previously diagnosed as MFH and its relation to clinical outcomes.

Entities:  

Mesh:

Year:  2004        PMID: 15641745

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  8 in total

Review 1.  Malignant fibrous histiocytoma/undifferentiated high-grade pleomorphic sarcoma of the maxillary sinus: report of a case and review of the literature.

Authors:  Drazsen Vuity; Sandor Bogdan; Katalin Csurgay; Zoltan Sapi; Zsolt Nemeth
Journal:  Pathol Oncol Res       Date:  2013-06-29       Impact factor: 3.201

2.  A case of primary malignant fibrous histiocytoma of the pancreas: CT and MRI findings.

Authors:  Ri-Sheng Yu; Jia-Wei Wang; Ying Chen; Wen-Hong Ding; Xiu-Fang Xu; Li-Rong Chen
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

Review 3.  NF1 diagnosis criteria and associated sarcomatous tumor review of the literature and case report.

Authors:  Márcia Gaiger de Oliveira; Sabrina Pozatti Moure; Paulo Sérgio Batista; Anna Cecília Moraes Chaves; Pantelis V Rados; Manoel Sant'Ana Filho
Journal:  Oral Maxillofac Surg       Date:  2008-12

4.  MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.

Authors:  Marcus Lehnhardt; Adrien Daigeler; Heinz H Homann; Vanessa Schwaiberger; Ole Goertz; Cornelius Kuhnen; Hans U Steinau
Journal:  Langenbecks Arch Surg       Date:  2008-06-27       Impact factor: 3.445

Review 5.  MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century.

Authors:  Igor Matushansky; Elizabeth Charytonowicz; Joslyn Mills; Sara Siddiqi; Todd Hricik; Carlos Cordon-Cardo
Journal:  Expert Rev Anticancer Ther       Date:  2009-08       Impact factor: 4.512

6.  Malignant fibrous histiocytoma--pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.

Authors:  Adrien Daigeler; Daigeler Adrien; Ludger Klein-Hitpass; Klein-Hitpass Ludger; Ingo Stricker; Stricker Ingo; Oliver Müller; Müller Oliver; Cornelius Kuhnen; Kuhnen Cornelius; Ansgar Michael Chromik; Chromik Ansgar Michael; Lars Steinstraesser; Steinstraesser Lars; Ole Goertz; Goertz Ole; Hans-Ulrich Steinau; Steinau Hans-Ulrich; Marcus Lehnhardt; Lehnhardt Marcus
Journal:  Langenbecks Arch Surg       Date:  2009-01-22       Impact factor: 3.445

Review 7.  Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis.

Authors:  Mariko Murata; Raynoo Thanan; Ning Ma; Shosuke Kawanishi
Journal:  J Biomed Biotechnol       Date:  2012-01-26

8.  Undifferentiated Pleomorphic Sarcoma of Pancreas: A Case Report and Review of the Literature for the Last Updates.

Authors:  Behnam Sanei; Amirhosein Kefayat; Melika Samadi; Parvin Goli; Mohammad Hossein Sanei; Fatemeh Ghahremani; Alireza Amouheidari
Journal:  Case Rep Med       Date:  2018-05-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.